DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Guha, Minakshi ^a   Castellanos Rizaldos, Elena ^a   Makrigiorgos, G Mike ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; LOCKED NUCLEIC ACID; METHIONINE; PEPTIDE NUCLEIC ACID; THREONINE; DNA; GEFITINIB; OLIGONUCLEOTIDE; QUINAZOLINE DERIVATIVE;

ALLELE; ANALYTIC METHOD; ARTICLE; CANCER GENETICS; CANCER RESISTANCE; CONTROLLED STUDY; DIFFERENTIAL STRAND SEPARATION AT CRITICAL TEMPERATURE METHOD; EGFR GENE; GENE IDENTIFICATION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MUTANT; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; WILD TYPE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; DNA SEQUENCE; DRUG RESISTANCE; EXON; GENETICS; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; MALE; METABOLISM; MUTATION; PROCEDURES; TUMOR CELL LINE;

ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; EXONS; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; OLIGONUCLEOTIDES; PEPTIDE NUCLEIC ACIDS; POLYMERASE CHAIN REACTION; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE ANALYSIS, DNA;

EID: 84879258245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067782     Document Type: Article

References (22)

1. Perez-Soler R, Chachoua A, Hammond LA, Rowinsky EK, Huberman M, et al. (2004) Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol 22: 3238-3247.
2. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500.
3. Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, et al. (2005) EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352: 786-792.
4. Kosaka T, Yatabe Y, Endoh H, Yoshida K, Hida T, et al. (2006) Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clin Cancer Res 12: 5764-5769.
5. Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, et al. (2005) Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2: e73.
6. Kuang Y, Rogers A, Yeap BY, Wang L, Makrigiorgos M, et al. (2009) Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer. Clin Cancer Res 15: 2630-2636.
7. Milbury CA, Li J, Makrigiorgos GM, (2009) PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem 55: 632-640.
8. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, et al. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706-709.
9. Tada M, Omata M, Kawai S, Saisho H, Ohto M, et al. (1993) Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472-2474.
10. Nagai Y, Miyazawa H, Huqun, Tanaka T, Udagawa K, et al. (2005) Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 65: 7276-7282.
11. Miyazawa H, Tanaka T, Nagai Y, Matsuoka M, Sutani A, et al. (2008) Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation. Cancer Sci 99: 595-600.
12. Nielsen PE, Egholm M, (1999) An introduction to peptide nucleic acid. Curr Issues Mol Biol 1: 89-104.
13. Engelman JA, Mukohara T, Zejnullahu K, Lifshits E, Borras AM, et al. (2006) Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. J Clin Invest 116: 2695-2706.
14. Guha M, Castellanos-Rizaldos E, Liu P, Mamon H, Makrigiorgos GM (2012) Differential strand separation at critical temperature: A minimally disruptive enrichment method for low-abundance unknown DNA mutations. Nucleic Acids Res.
15. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
16. Milbury CA, Li J, Makrigiorgos GM, (2009) COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. Clin Chem 55: 2130-2143.
17. Li J, Janne PA, Makrigiorgos GM, (2011) Biotinylated probe isolation of targeted gene region improves detection of T790M epidermal growth factor receptor mutation via peptide nucleic acid-enriched real-time PCR. Clin Chem 57: 770-773.
18. Li J, Wang L, Janne PA, Makrigiorgos GM, (2009) Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR. Clin Chem 55: 748-756.
19. Amicarelli G, Shehi E, Makrigiorgos GM, Adlerstein D, (2007) FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations. Nucleic Acids Res 35: e131.
20. Li J, Makrigiorgos GM, (2009) COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing. Biochem Soc Trans 37: 427-432.
21. Milbury CA, Li J, Makrigiorgos GM, (2011) Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations. Nucleic Acids Res 39: e2.
22. Li J, Milbury CA, Li C, Makrigiorgos GM, (2009) Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma. Hum Mutat 30: 1583-1590.